longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

AJJ Medtech

584

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -2.06, within the reasonable range, cheaper than 43.04% of the time in the past 3 years, and the industry ranks 1/4, the industry Median -4.65.

-2.06xP/E
S$0.00Stock price
S$-0.00Earnings per share
-2.06xP/E
Stock priceS$0.00Earnings per shareS$-0.00

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-2.18x
Typical range
-2.92x–-1.58x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
01234

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x0.2x0.4x0.6x0.8x1x
P/E ratio
Name/Symbol
8YYSGEFH
-21.04x--S$64.14M
569SGVicplas
-5.84x--S$35.26M
V8YSGQuantum Health
-4.65x--S$12.59M
584SGAJJ Medtech
-2.06x--S$6.93M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.